A Phase 2 interventional study of Qualified exercise professional support and Exercise apps in Exercise Adherence (Primary), Depressive Symptoms (Secondary) and Anxiety (Secondary), sponsored by University of British Columbia. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University of British Columbia · Phase 2, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Depression by University of British Columbia — 9 open to participants now, 10 under way, 1 of them phase 3. Depression · University of British Columbia.
Among the 34 studies in Depression by University of British Columbia, this one is the 2nd largest by planned enrollment, is the only one that started in 2026, is one of 3 in phase 2, and was the 34th registered.
8,595 studies on the registry are indexed under Depression; 1,732 are open to participants now.
Browse Depression studies →9 of the 34 studies in Depression by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:
University of British Columbia · Sites in Canada
Ages 40–80
University of British Columbia · Sites in Canada
Ages 19–70
University of British Columbia · Sites in Canada
Ages 19–65
University of British Columbia · Sites in Canada
Ages 18–65
University of British Columbia · Sites in Canada
Ages 18+
By country, each count listing its studies:
Of the 1,094 Depression studies recruiting now, 472 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 314 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 664 is above the median of 81 across 7,078 interventional studies indexed under Depression.
Median enrollment 76 across the 34 interventional studies. Of the 20 that completed or were terminated, 3 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of British Columbia is the lead sponsor of 1,341 studies on the registry; 261 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.
2 of the studies in Depression by University of British Columbia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05423275University of British ColumbiaLight and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study | 2026-12 |
| NCT04999553University of British ColumbiaLeft vs. Right Non-Inferiority Trial | 2027-06-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 34 studies in Depression by University of British Columbia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Healthcare workers report significantly worse mental health and wellbeing than the average employed Canadian. Evidence suggests that healthcare workers' leisure-time physical activity is associated with higher mental and physical health, while occupational physical activity is not. Our pilot work demonstrated that previously inactive healthcare workers who develop sustained off-site, at-home exercise routines using mobile applications (apps) have improved depressive symptoms and burnout, and lower rates of sick leave. Yet, in our work, only 23% of healthcare workers remained engaged with the apps for at least 80 or more minutes on average per week at the end of the 12-week study. In semi-structured interviews completed following their participation in the study, healthcare workers voiced their desire to have support from our team to help them maintain their motivation and improve their adherence. Here, we propose to conduct a randomized trial with two conditions of an aerobic exercise mobile app (using a suite of apps for whole body weight-based training, yoga, pilates, and barre) with or without support from a qualified exercise professional trained in motivational interviewing to improve healthcare workers' engagement with the suite of apps in their leisure time. In turn, we aim to improve their mental health and wellbeing as their exercise levels increase. By targeting adherence, our goal is to develop a feasible, engaging, and accessible solution that can be implemented as a more widely utilized program in the future, for healthcare workers and beyond.
Healthcare workers (HCWs) represent the largest group of government employees in Canada. Regulated nurses, including registered nurses, nurse practitioners, licensed practical nurses, and registered psychiatric nurses, are the most prevalent, with registered nurses accounting for more than 93% of HCWs across the country. Shift work, high job strain, and low autonomy have each been associated with poorer physical and mental health among nurses. Likewise, physicians experience high levels of stress and face an elevated risk of burnout and illness. While previous research has shown improvements in health and wellbeing following an exercise intervention, less than one-quarter of healthcare workers fully engaged with the intervention by the end of the study.
Considering the above, the investigators propose a 2-arm parallel randomized efficacy trial, the Remote Exercise iNtErvention for Wellbeing (RENEW) trial, to support HCWs to convert intentions into maintenance. The present study will test whether supplementing free access to Down Dog™ applications (apps) with free support from a qualified exercise professional (QEP) trained in behaviour change techniques and motivational interviewing can lead to (1) improved adherence (i.e., increased moderate-to-vigorous physical activity; primary outcome) which, in turn, should lead to (2) improved mental health, wellbeing, and occupational functioning (secondary outcomes). Based on systematic reviews and meta-analyses demonstrating more sessions are more effective (with a minimum of 5 sessions), and with no standards yet to be recommended, we will provide 7 QEP-led sessions during the first 9 weeks, followed by 4 additional monthly boosters until the end of the trial. All participants will receive free access to Down Dog™'s suite of apps. Down Dog™ apps were selected for several reasons: i) variety of exercise options: body-weight interval training, yoga, barre, pilates; ii) diversity in difficulty levels (0-3), type (e.g., aerobic and/or resistance for interval training app), length of workout (4-60 min), interval bout (10-120 sec), and recovery time between bouts (0-60 sec); iii) no requirement for equipment; and iv) choice of music, language, and gender of the narrators and models in the videos.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
* For the duration of the study, participants will be completing any of the physical activities customizable within the Down Dog™ applications (apps). Participants can also be supported to complete physical activity outside of the apps. They will be asked to complete a minimum of 90 mins/week of structured, planned exercise. * Participants will engage in 7 sessions led by qualified exercise professionals (QEPs) trained in Motivational Interviewing every week during the first 4 weeks and every 2 weeks for the following month. Starting at week 9, monthly booster sessions will be provided until end of month 6. Sessions will be held over Zoom™. * Participants will receive weekly and monthly surveys to complete. They will also complete a baseline prior to Week 1 and a final survey at the end of Week 24. * Participants will be shipped an ActiGraph Leap 2.0 device to wear once a month for 7 days, throughout their awake daily life for the measurement of physical activity outside of app use.
Behavioral: Qualified exercise professional support · Behavioral: Exercise apps
* For the duration of the study, participants will be completing any of the physical activities customizable within the Down Dog™ applications (apps). They will be asked to complete a minimum of 90 mins/week. * Participants will receive weekly and monthly surveys to complete. They will also complete a baseline prior to Week 1 and a final survey at the end of Week 24. * Participants will be shipped an ActiGraph Leap 2.0 device to wear once a month for 7 days, throughout their awake daily life for the measurement of physical activity outside of app use.
Behavioral: Exercise apps
Participants randomized to the Apps + QEP group will meet with qualified exercise professionals (QEPs) trained in motivational interviewing. The first session will occur on Zoom™ within 1 week of randomization for a maximum 1-hour session to determine motivation and goals, and set workouts. These will be followed by maximum 30-minute sessions every week during the first four weeks (at the end of wks 1, 2, 3, 4) and every 2 weeks for weeks 5 through 8 (wks 6, 8) for a maximum of 30 minutes per session. Starting at week 12, monthly booster sessions (30 minutes max) will be provided until end of month 6. During sessions, QEPs will review progress and foster self-determined motivation. Drs. Ma and Puterman trained 10 QEPs (minimum Certified Person Trainer, Kinesiologist, or Clinical Exercise Physiologist) with a Bachelor's degree in Kinesiology including an advanced exercise prescription course. QEPs are provided with training in physical activity counselling and motivational interviewing.
All participants will receive free access to a suite of exercise applications (apps) from Down Dog™ for whole body weight-based training, yoga, pilates, and barre. Participants will be asked to exercise for a minimum of 90mins/week. Exercises can be completed at home or in any other preferred location, and with or without exercise equipment.
Exercise Engagement
Leisure-time moderate-to-vigorous physical activity (MVPA) will be assessed using a combination of 7-day usage for the Down Dog™ applications (apps) and any additional MVPA with the research-grade ActiGraph LEAP 2.0 accelerometer at baseline for 7 days prior to randomization, and every 4 weeks up to 24 weeks (weeks 4, 8, 12, 16, 20, and 24).
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Depressive Symptoms
Assessed with the Center for Epidemiologic Studies Depression Scale-10-item (CESD-10). This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 30, with higher scores indicating more or more frequent symptoms.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Anxiety Symptoms
Assessed with the Generalized Anxiety Disorder-7 Scale (GAD-7). This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 21, with higher scores indicating more or more frequent symptoms.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Perceived Stress
Assessed with the Perceived Stress Scale 4-item (PSS-4). This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 16, with higher scores indicating more or more frequent symptoms.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Psychological Flourishing
Assessed with the Flourishing Scale. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 56, with higher scores indicating higher self-perceived success in important areas of functioning.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Well-being
Assessed with the WHO Well-Being Index. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 25, with higher scores indicating greater feelings of positive well-being.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Resilience
Assessed with the Brief Resilience Scale. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 30, with higher scores indicating greater self-perceived ability to recover from stressful events.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Burnout
Assessed with the 22-item Maslach Burnout Inventory-Human Services Survey (MBI-HSS) for HCWs. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Includes 5 items that measure cynicism (also referred to as depersonalization). Possible range in scores is 0 to 30, where higher scores indicates greater burnout. Includes 9 items that measure emotional exhaustion. Possible range in scores is 0 to 54, where higher scores indicates greater burnout. Includes 8 items that measure professional efficacy (previously referred to as personal accomplishment). Possible range in scores is 0 to 48, where higher scores indicates lower burnout.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Absenteeism and Presenteeism
Assessed with the WHO Health and Work Performance Questionnaire (HPQ) Short Form. This will be completed on a weekly basis up to 24 weeks, including at baseline. The absenteeism question (number of days reported missing work for health or vacation) will be asked weekly. Presenteeism will be asked monthly, and assesses past-month self-rated overall work performance. Possible range in scores for presenteeism is 0 to 30, with higher scores indicating more positive self-perceived job performance.
Time frame: Tracked every week for 24 weeks (baseline, up to 24 weeks)
Intention to Leave Profession
Assessed with the 3-item Turnover Intentions Scale. This will be completed on a weekly basis up to 24 weeks, including at baseline. Possible range in scores is 3 to 18, with higher scores indicating greater intentions to leave one's current job.
Time frame: Tracked every week for 24 weeks (baseline, up to 24 weeks)
Determinants of Physical Activity
Assessed with the 34-Item Determinants of Physical Activity Questionnaire. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 34 to 238, with higher scores indicating lower perceived barriers to engaging in physical activity across the contexts of physical activity knowledge, environmental factors, relationships and self-beliefs.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Intervention Delivery
Assessed with the 11-item Client Experience of Motivational Interviewing Questionnaire. This will be included in each monthly survey (weeks 4, 8, 12, 16, 20, and 24) for participants randomized into the Apps + QEP (qualified exercise professional) arm. Possible range in scores is 11 to 55, with higher scores indicating more positive experience receiving motivational interviewing intervention.
Time frame: Tracked every 4 weeks up to 24 weeks
Pain
Assessed with the 5-item PROMIS Pain Questionnaire. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 4 to 30, with higher scores indicating greater experiences of symptoms and interference with important areas of functioning.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Sleep Quality
Assessed with the single-item Sleep Quality Scale. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 10, with higher scores indicating better quality of sleep.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Musculoskeletal Injury
Assessed with the the Nordic Musculoskeletal Questionnaire, shortened and adapted to briefly assess the past month. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). This survey uses a multiple choice response style.
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Physical Health Symptoms
Assessed with a survey instrument developed by the research team to track health symptoms. This survey uses a multiple choice response style and will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24).
Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)
Chronic Health Symptoms
Assessed with a survey instrument developed by the research team to track identify chronic health symptoms. This survey uses a multiple choice response style and will be included in the baseline survey only.
Time frame: Tracked at baseline
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — All shared data will have all identification removed (i.e., de-identified data). All data used in analyses in a publication will be made available online.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: Data will be shared following the publication of results.
Access criteria: Academic researchers conducting scientific analyses should submit a written request to the Principal Investigator.
Start is estimated for Nov 2026; primary completion for Oct 2029, 35 months later.
Of 143 non-industry phase 2 interventional studies under Depression, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 57. This study's planned 35 months is close to that.
Counting every sponsor, half of 196 studies reached it within 31 months; a quarter within 18 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of British Columbia →